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Abstract  
Objective: To examine the trends of all-cause natural mortality for people aged 15+ years in a remote 
Australian Aboriginal community between 1996 and 2010. 
Methods: The annual population in the community by gender and age group was obtained from the 
Australian Bureau of Statistics (ABS). All known deaths and all records of start of renal replacement 
therapy (RRT) for renal failure were recorded between 1996 and 2010.  Five year aggregated death 
rates were calculated and the changes in natural mortality over the interval were evaluated. Mortality 
was compared with those of the Northern Territory (NT) Indigenous and non-Indigenous people as a 
whole from 1998 to 2006.  
Results:  Rates of natural deaths were progressively lower in the third interval 2006-2010 relative to 
the first interval 1996-2000, with higher, but more rapidly falling rates for females than males.  
Reductions were most prominent for both sexes in the 65+ age groups, but death rates in females of 
earlier middle age also trended lower. The trends applied whether or not the starting of RRT was 
considered as a natural death.  There was a similar trend in rates of natural death in the aggregate 
Indigenous population of NT. 
Conclusions:  The downward trends probably reflect improvements in risk factor status since the 
1960s, all-of-life health interventions, as well as better chronic disease management in the last two 
decades. The higher death rates in females than males in this community remain unexplained, but the 
rapid rate of decline of female death rates predicts that this gap will soon be minimised.  
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Australian Indigenous people, particularly those living in remote areas, experience significantly higher 
all-cause mortality, cardiovascular deaths and end-stage renal disease, compared to those in 
mainstream Australians. 1-6 Other reports show that long term mortality has been improving for NT 
Indigenous people since the 1990s, and the increase in death rates for the major chronic disease has 
been slowing. 7-9 We have recently described reductions in deaths from chronic disease in indigenous 
people in the NT, and again, in remote/very remote living Indigenous people nationwide.10,11  
One particular remote community in the Top End Northern Territory, which has participated in ongoing 
research and surveillance for more than 20 years, historically has had the highest rates of renal failure 
described globally, and a 6-fold increase in all-cause natural deaths relative to non-Indigenous 
Australians.1,12  In 1911, the Catholic Church founded a mission that was one of the earliest sites for 
improved health service delivery. This was one of the earliest communities in remote areas of 
Australia to experience dramatic reductions in infant and childhood mortality, as we have described 
between the mid 1950s to the 1980s. 13 It was the also site of the first community-based dialysis unit, 
which was established about 14 years after the first community member started renal replacement 
treatment (RRT) in 1985, the setting in which the benefit of regular chronic disease surveillance and 
treatment in reducing natural deaths and renal failure was demonstrated, 14 and the first Australian 
site where the contribution of low birthweight to chronic disease and to chronic disease deaths has 
been demonstrated. 13, 15, 16. 
We have followed health profiles and terminal events in this population since 1992.  Here we describe 
the trend of mortality for residents aged 15+ years between 1996 and 2010.  
Methods 
The profiles of this community have been described previously.17, 18 The Aboriginal populations in this 
community were estimated based on ABS census data in 1996, 2001, 2006 and 2011. 19, 20  The 
annual Aboriginal population by age and sex for interval 1996-2000 was estimated using the average 
census figure between 1996 and 2001; the second interval 2001-2005 was based on the average 
census figure between 2001 and 2006 and the third interval 2006-2010 was based on the average 
census figure between 2006 and 2011. There were a total of 1,833 Aboriginal people in 1996 census, 
and 2,267 in 2011 census, with 70% of people aged 15+years in 1996 and 69% in 2010. 19, 20  The 
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population is spread out over three main communities on two islands, with three main community 
clinics.  The annual mortality was examined for subjects aged 15 years and over between 1st January 
1996 and 31 December 2010. The documentation of deaths, natural and unnatural, has been 
described previously.13, 14, 16 They were taken from community log books of deaths, whether they 
occurred in the community or in hospital, that were maintained by clinic staff, with the causes and 
associations described in narrative. This is a unique and valuable resource, because there were no 
community-specific death data available from the ABS.  The currency of those community death 
records was checked at intervals through direct enquiry at each of the three community clinics. The 
identity and fate of individuals unknown to the investigators was checked through health workers and 
senior community members. The documentation of individuals starting dialysis was through the 
regional (Darwin-based) dialysis unit initially, supplemented later by the local dialysis unit records, and 
is known to be complete. Deaths were confirmed through the local Catholic Church Burial and Funeral 
Record, made available to the investigators through the kindness of Father Pat Han.  
The annual age and sex-specific death rates were aggregated over each of three 5-year intervals, i.e. 
1996-2000, 2001-2005 and 2006-2010, and the trends over those intervals were evaluated.  Two 
approaches to the definition of death were taken.  The first is the occurrence of death as commonly 
accepted, when an individual actually expires.  The second is the consideration of the start of renal 
replacement therapy as a natural death of renal causes. This concept, commonly used in nephrology, 
acknowledges that without institution of RRT that person would have died of terminal renal failure 
within weeks or a few months. It provides a standard by which mortality rates can be compared over 
time, independent of the changing availability or application of RRT (and across populations 
regardless of the availability of RRT).  It also allows a more accurate assessment of causes of death, 
which is critical for targeted interventions. Although people who start dialysis have actually 
experienced a “renal death”, when they actually expired their recorded cause of death they usually 
reflects other process, most commonly cardiovascular disease, which is a usual accompaniment of 
renal disease. In fact, in a large proportion of people dying on RRT Australia-wide, a renal contribution 
to death is not even acknowledged.21 By the only existing published estimates, the introduction of 
RRT in a remote living Aboriginal person in the NT prolongs life by a median of about 3.5 years: thus 
community-based life expectancy that does not acknowledge RRT as a “renal death” will always 
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exceed the “renal death” life expectancy, to an extent dependent on the number of people on RRT at 
any time.    
Mortality data for Indigenous and non-Indigenous people in the Northern Territory (NT) between 1998 
and 2006 were obtained from ABS in the form of de-identified death unit record files, and were used 
for comparison with the aggregated mortality data in the study community during the same period. 
The underlying cause of death was determined from the 10th version of the International classification 
of diseases (ICD-10) associated with the NT mortality data. The coding includes: all cause death 
codes between A00 and Y98 and all natural death codes between A00 and R95. These ABS death 
data address final expiration only, and do not accommodate considerations of RRT or calculations of 
renal-inclusive natural deaths.  
The estimated resident populations of NT were derived from ABS publications. 22, 23 Mortality data for  
NT people were indirectly standardised for age and sex using the demographic structure of this study 
community as a reference population.  
All data management and statistical analyses were undertaken using Stata 11.1 (Stata Corp. Stata 
Statistical Software: Release 11.1, College Station. TX: StataCorp LP, 2009). Pearson's Chi-square 
test was applied to examine the difference in death rates between different interval periods. The 
standardised mortality ratios (SMRs) and mid-P exact 95% confidence intervals were also 
determined. Statistical significance was defined at the level of p <0.05 (two-tailed) or if the 95% 
confidence interval of SMR did not include 1.0. 
This study was approved by the Ethics Committee of the Menzies School of Health Research and 
Territory Health Services and The Behavioural and Social Science Ethical Review Committee of the 
University of Queensland within the broader context of a longitudinal study of the community. 
Results 
Profiles of deaths 
There were 176 all-cause deaths in males over the overall study interval. Of these, 64 were deaths 
from misadventure, such as accidents, suicides and homicides and mostly in young adults. There 
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were 112 male deaths from natural causes, four of which were infants and were not considered 
further. Eight males were on dialysis at the start of the observation period, and another 19 started 
dialysis during the observation periods (1996-2010). Eighteen males on dialysis died during the 
observation periods, and 9 were still alive at the end of the observation period.  Therefore the 
following analysis focuses on the 108 “true” natural deaths and 117 “deaths” if 9 participants who 
started dialysis were included for males aged 15 year and older (“adults” by WHO definition) 
There were 150 all-cause deaths among females: of these 11 were deaths from misadventure, and 
139 were natural deaths. Five of these were infant deaths and not considered further. Nine females 
were already on dialysis at the start of the observation period, another 39 started dialysis during the 
observation period. A total of 32 females on dialysis died during the observation interval and 16 were 
still alive on dialysis at the end of the observation period. The 134 “true” natural deaths, and 150 
“deaths” if 16 participants who started dialysis were included for females aged 15+ years, were the 
subjects of this analysis.   
Trend in mortality by age and sex   
Tables 1 and 2 show the numbers of natural deaths of subjects aged 15+ years by gender and 10- yr 
age group. The first row “a” in each age group gives the number and rates of “true” natural deaths, 
while the second entry ”b” shows the same data including dialysis starts as renal death, which are, of 
course, generally higher.  Deaths rates increased with increasing age. The table also shows that the 
total number of deaths by both definitions remained fairly stable over time, despite the increasing size 
of the populations at most risk. There were apparent reductions in mortality in the third interval relative 
to the first interval in both sexes and mortality in females decreased steadily over the whole 
observation period especially in females aged 65+ years. This is demonstrated for the composite 
definition of death that includes start of RRT as a renal death in Figures 1 and 2.  Trends of deaths 
defined as final expiry were similar, around somewhat lower rates.  For people aged 65 +, the trend 
was significant for males (p=0.041) and all persons (p=0.016) while it was not significant for females  
(p=0.196).    
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Figure 3 shows the trends in natural death for this population over the study period. It also shows 
falling mortality from natural deaths in the aggregated Indigenous population in the NT.  Analyses 
showed that NT Indigenous people aged 50-64 years and aged 65+ years had the highest death rate 
reduction (data not shown). The high mortality rates in general and the higher rates in females in this 
community are one substantial difference.  However, the steep downward trend in females predicts 
that this gap between the sexes will soon be minimised.    
From 1998-2006, the SMRs of all-cause natural mortality for males aged 15+ years in this community 
compared with NT Indigenous males was 1.17 (95% CI: 1.10-1.24) and compared with non-
Indigenous males was 5.39 (5.09-5.72). The SMRs for females in this community were 1.84 (1.74-
1.94) compared with the NT Indigenous females, and 6.77 (6.41-7.13) compared with non-indigenous 
females. 
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Table 1 Profiles of natural death in males by age groups.   
  1996-2000   2001-2005   2006-2010     
age group death no. population              death rate*  death no. population              death rate  death no. population              death rate    
15-24 
          a 1 1115 89.7 (2.3-498.7) 0 1050 0.0 0 998 0.0 
 b 1 1115 89.7 (2.3-498.7) 0 1050 0.0 0 998 0.0 
 25-34 
          a 2 893 224.0 (271.3-806.7)  3 863 347.6 (71.8-1012.5) 1 900 111.1 (2.8-617.5) 
 b 2 893 224.0 (271.3-806.7)  3 863 347.6 (71.8-1012.5) 1 900 111.1 (2.8-617.5) 
 35-44 
          a 9 635 1417.3 (650.1-2673.4) 12 728 1648.4 (854.6-2861.6) 6 788 761.4 (279.9-1649.9) 
 b 10 635 1574.8 (757.7-2877.0) 12 728 1648.4 (854.6-2861.6) 7 788 888.3 (357.9-1821.6) 
 45-54 
          a 8 420 1904.8 (825.8-3718.5) 10 458 2183.4 (1051.9-3978.6) 9 515 1747.6 (802.1-3291.4) 
 b 9 420 2142.9 (984.4-4028.7) 11 458 2401.7 (1204.9-4256.7) 11 515 2135.9 (1071.0-3789.6) 
 55-64 
          a 6 163 3681.0 (1362.6-7839.5) 8 190 4210.5 (1835.1-8127.6) 10 225 4444.4 (2151.6-8021.4) 
 b 6 163 3681.0 (1362.6-7839.5) 9 190 4736.8 (2188.6-8801.3) 12 225 5333.3 (2785.8-9130.9) 
 65+ 
          a 10 63 15873.0 (7883.4-27259.8) 5 88 5681.8 (1870.4-1276.3) 8 130 6153.8 (2694.0-11765.5) 
 b 10 63 15873.0 (7883.4-27259.8) 5 88 5681.8 (1870.4-1276.3) 8 130 6153.8 (2694.0-11765.5) 
 all  
          a 36 3289 1094.6 (767.8-1512.1) 38 3377 1125.3 (797.5-1541.3) 34 3556 956.1 (663.0-1333.6) 
 b 38 3289 1155.4 (818.9-1582.4) 40 3377 1184.8 (847.5-1609.5) 39 3556 1096.7 (781.0-1496.3) 
 Notes: * aggregated death rate per 100,000 populations (95% CI);  a- “true” natural death; b- same natural death data plus number starting dialysis 
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Table 2 Profiles of natural death in females by age groups   
  1996-2000   2001-2005   2006-2010   
  death no. population            death rate*  death no. population              death rate  death no. population         death rate  
15-24 
         a 1 1040 96.2 (2.4-534.6) 1 948 105.5 (2.7-586.3) 0 930 0.0 
b 1 1040 96.2 (2.4-534.6) 1 948 105.5 (2.7-586.3) 0 930 0.0 
25-34 
         a 1 880 113.6 (2.9-631.5) 1 878 113.9 (2.9-632.9) 3 855 350.9 (72.4-1022.0) 
b 1 880 113.6 (2.9-631.5) 2 878 227.8 (27.6-820.4) 3 855 350.9 (72.4-1022.0) 
35-44 
         a 6 645 930.2 (342.1-2013.7) 5 713 701.3 (228.1-1628.9) 5 828 603.9 (196.4-1403.6) 
b 8 645 1240.3 (537.0-2429.2) 7 713 981.8 (395.6-2012.3) 10 828 1207.7 (580.6-2209.8) 
45-54 
         a 9 448 2008.9 (922.6-3779.2) 13 500 2600.0 (1391.5-4405.0) 12 605 1983.5 (1029.0-3439.1) 
b 9 448 2008.9 (922.6-3779.2) 14 500 2800.0 (1539.1-4653.3) 12 605 1983.5 (1029.0-3439.1) 
55-64 
         a 10 185 5405.4 (2622.2-9715.9) 10 210 4761.9 (2306.8-8582.8) 10 295 3389.8 (1637.3-6145.5) 
b 10 185 5405.4 (2622.2-9715.9) 11 210 5238.1 (2643.5-9179.0) 14 295 4745.8 (2618.5-7834.5) 
65+ 
         a 20 145 13793.1 (8633.2-20495.6) 16 150 10666.7 (6221.1-16743.6) 11 150 7333.3 (3717.5-12742.4) 
b 20 145 13793.1 (8633.2-20495.6) 16 150 10666.7 (6221.1-16743.6) 11 150 7333.3 (3717.5-12742.4) 
all  
         a 47 3343 1405.9 (1034.8-1865.2) 46 3399 1353.3 (992.5-1801.1) 41 3663 1119.3 (804.4-1515.4) 
b 49 3343 1465.7 (1086.3-1933.2) 51 3399 1500.4 (1119.2-1968.1) 50 3663 1365.0 (1014.8-1795.7) 
Notes: * aggregated death rate per 100,000 populations (95% CI);  a- “true” natural death; b- same natural death data plus number starting dialysis 
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Figure 1 Natural death rate in males by age groups and intervals  
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Figure 2 Natural death rate in females by age groups and intervals 
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                                           Figure 3 Comparison of all-cause natural death rate between Tiwi community and NT people aged 15 years+ 
                            
Notes:  Data for this Aboriginal remote community were aggregated death rate for period 1996-2000, 2001-2005 and 2006-2010 respectively; data for NT Indigenous 
and non- Indigenous people were for period 1998-2000, 2001-2003 and 2004-2006 respectively, and NT data were indirectly standardised for age  using this Aboriginal 
remote community as the reference population.  
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Discussion 
Trends in mortality  
The study confirms very high death rates from natural causes in this remote Aboriginal community.  It 
also shows the astonishing rates of terminal renal failure, reflected in the numbers of people starting 
dialysis during the observation interval. These constituted 19/117 or 16.2% of all adult males and 
39/150 or 26.0% of adult female natural deaths by the comprehensive renal-inclusive definition. 
These must be considered in analysis of mortality rates. From previous estimates in this setting,14  we 
know that institution of RRT in people with terminal renal failure extends survival by a median of 3.5 
years, which will be reflected in reduced overall mortality.  On average, in this community, rates of 
natural death by the renal-death inclusive definition are 8% higher in males and 12 % higher in 
females than the rates of natural death calculated on final expiry.  However, institution of RRT, by 
prolonging survival, supplements the numbers of people in older age groups (survivors to this point) 
with individuals with a seriously shortened life expectancy.  In this study specifically, of people 
expiring from natural causes, 18/108 (16.7%) of males and 32/134 (23.9%) females were already on 
RRT. These people had been experiencing the modest extension of life expectancy conferred by RRT 
and were surviving to populate older age groups, where, through dying prematurely nonetheless, they 
could exacerbate mortality rates in those age groups beyond historical levels. 
For purposes of comparing mortality rates with those of other populations for whom RRT is not 
generally available, the valid statistic is the expanded definition of death, which includes institution of 
RRT as an endpoint.  For accurate ascertainment of cause-specific contributions to death, and 
therefore to potentially guide targeted interventions, this is also the correct statistic to employ. 
However, comparison with other mortality statistics in Australiia can only employ the “final expiry” 
statistic, because consideration and timing of RRT is not included those datasets.  Such statistics, 
however, understate the contribution of renal disease to deaths, and overstate the contributions of 
other conditions, usually cardiovascular events, from which patients on RRT usually die.  
This study also shows downward trends in rates of all-cause natural death in the third consecutive 5-
year intervals relative to the first interval. Absolute numbers of adult deaths have not risen, despite 
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generally larger population denominators, most markedly in older age groups. The trends applied 
whether people who started RRT were considered as deaths when (and if) they actually died during 
the observation intervals, or whether they were considered as deaths at the start of RRT.  The trends 
were largely restricted to the people age 65+ years.  Females, who started from a much higher 
mortality rate in the first interval, had a more marked reduction, which, if sustained, predict that their 
mortality rates might approach those of males within the next decade.  These reductions predict 
continued ageing of the population, as is already evident in the larger numbers of people aged 65+ in 
the last interval compared with the first interval, and which is mirrored in an increase in the total 
population. For example, the aggregated number of Aboriginal people aged 65 + in this community 
has increased from 63 during 1996-2000 to 130 during 2006-2010 for males, and from 145 to 150 for 
females. 19, 20 These are important trends.   
The credibility of these findings is supported by a similar trend  we reported in natural deaths rates of 
males and females in the aggregate Indigenous population of the NT.10 That past work also showed 
that mortality in Indigenous people were higher in remote areas. 24 Moreover the findings are 
compatible with the recent falling mortality, both as absolute numbers of deaths and as rates, which 
our group has described in remote communities across Australia in all states/territories that have 
adequate Indigenous assignment. 11 However, data from our study community differ from the territory-
wide data in the relative excess mortality rates for females.  
That excess mortality in females is paralleled by the greater predisposition of females to renal failure, 
with an age-adjusted incidence more than twice that of men in this community.  In fact, a female 
predominance is reflected in RRT data in remote Indigenous communities nationwide. 5 This 
predisposition results not only in higher rates of renal-inclusive natural deaths, but, given the short life 
expectancy of people on dialysis, also in higher rates of natural deaths defined as final expiry.  The 
heightened mortality risk in females is marked by their higher prevalence of albuminuria which is more 
than twice as common as in males, 25 and marks the underlying renal disease. As we have shown 
repeatedly, and in this specific community, this albuminuria predicts, not only renal failure, but also 
the majority of nonrenal natural deaths. 17, 18, 26, 27.  Females also have higher rates of diabetes than 
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males throughout the life course, but we have previously shown that all the excess risk carried by 
diabetes is expressed through concomitant levels of albuminuria.16   
Factors contributing to excess of albuminuria in females probably include their demonstrated lower 
birthweights than males, historically and currently, 13, 16  their lack of relative protection against the 
endemic and epidemic poststreptococcal glomerulonephritis that is rife in this community,28 and their 
higher adult BMIs and rates of diabetes, all compounded by the lower nephron endowment, which is a 
characteristic of females generally. 29, 30 Regardless, it is certain that factors that will reduce or contain 
albuminuria will mitigate the excess mortality risk females rates are expressing. Moreover, if current 
rates of decline in mortality in females are maintained, it appears that this excess mortality gap will be 
greatly reduced or eliminated.  
Indigenous life expectancy in the NT has been improved significantly from the late 1960s. 31 The 
potential reasons for the improvement in life expectancy noted here are many. They include 
monumental changes in life style, environment, and nutrition, and continually improving health service 
delivery in all its dimensions of primary prevention (immunisations etc), disease mitigation and 
retrieval of patients from life-threatening complications.  Dramatic reductions in infant and childhood 
mortality since the mid 1960s have now allowed two generations of babies to survive to adult life, 
many of them the less robust babies of lower birthweights, who, as we have shown in this community, 
are at higher risk for chronic disease and chronic disease deaths as adults. 15,16 This phenomenon 
provides a partial explanation for the chronic disease epidemic, and hope for its mitigation as 
birthweights continue to improve.  More recently the application of systematic chronic disease 
surveillance and treatment protocols for people with early or established disease is improving health 
and delaying renal failure and death.  This approach, first modelled in this community in the late 
1990s, faltering later and then readopted, was evident in 2004-2006, when a community screen 
showed that 30.4% of adults overall, and 52% of those of 50+ years had prescriptions for angiotensin-
converting enzyme inhibitors, and 18.1% overall, and 34% of those age 50+ years had prescriptions 
for hypoglycaemic agents. 32 The principles of chronic disease surveillance and treatment have been 
endorsed nationally, are well supported by Medicare and PBS items, and increasingly applied in 
remote Indigenous health services nationwide.  Finally, we have shown, in this community, 
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improvement in some chronic disease risk factors in younger adults on no medication, between two 
community-wide health screens from 1992-1996, and 2004-2006, which indicate a true improvement 
in baseline health profiles, which we hope can be sustained. 32  
Strengths and limitations         
To our knowledge, this is the best long-term study of mortality available for remote Australian 
Aboriginal community so far.  The death information is as well documented as possible, combining 
data from clinical and burial records with certainty of community assignment provided by elders. The 
official deaths statistics do not provide those safeguards, and community assignment is incomplete in 
those statistics.  Furthermore, this is the only study that has accommodated considerations of RRT for 
people with renal failure, and is based in a community in which the recording of RRT has been 
meticulous. It demonstrates improved survival whether renal deaths are included as natural deaths at 
time of institution of RRT or whether the date of death is that of true expiry.  Findings are supported 
by a simultaneous fall in territory-wide Indigenous rates of natural death, which does not incorporate 
considerations of RRT.  An additional strength of this report lies in the good ascertainment of 
Indigenous status among deaths in the NT, ranging from 88% to 94% in 2005, 33 making the mortality 
comparison between this Aboriginal community and  NT Indigenous people more accurate, and the 
similar trends more reassuring.   
There are limitations in this study.  We have probably missed some deaths of people who were 
originally community members.  These were most likely people who had been long-term residents in 
other places, and who died and were buried elsewhere, without a ceremony in the community. Some 
people who died might also have been counted in the numerator but not in the denominator because 
the community was not their usual place of residence. This potential error might have lessened over 
the time as the team has been working with this community from 1992 onwards. In addition, there 
might also be some underestimation in the denominators supplied by ABS census data. However as 
the same approach was applied in the three 5-year observation intervals, results still reflect the actual 
trend change of death rate and  it is also a only reliable approach we can use in the analysis.  Finally, 
NT-wide Indigenous mortality data we used for comparison is subject to the vagaries of identfication 
and recording of Indigenous identifiers 34   
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Conclusion 
These data support and extend recent reports on improving mortality rates in remote indigenous 
people.  They probably reflect improvements in risk factor exposure since the 1960s, all-of-life health 
interventions, as well as better chronic disease management in the last two decades. The data are 
very encouraging for community members and health care providers alike. With decreased mortality 
for those aged 65+ years, the numbers of seniors will rapidly increase and the Life Expectancy Gap 
relative to Australians will be reduced. The higher death rates in females than males in this 
community are related to their higher rates of underlying renal disease. The rapid rate of decline in 
female death rates predicts that this gap will soon be minimised.  
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